Print Ad
![](https://judytabak.com/wp-content/uploads/2020/01/restokey_ad_2.jpg)
Print Ad
![](https://judytabak.com/wp-content/uploads/2020/01/restokey_ad_1.jpg)
Merck’s new entry into the field of oncology, MK-3475 promises to change the course of cancer treatment, allowing the body’s immune system to fight off cancer without damaging healthy cells. Happily, it was recently approved.
Creative Director / Copywriter / Marketing Strategist